Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of 8.36% is 26% above its 5-year average of 6.66%, near the high end of its 5-year range (0.95%–8.36%).
As of the fiscal period ended Saturday, December 27, 2025. 79.59% above its 12-month average of 4.65%.
Annual fiscal-year return on invested capital; no daily interpolation.
RETURN ON INVESTED CAPITAL (ROIC)
8.36%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
4.65%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
6.09%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
6.66%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
6.94%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
8.01%
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
7.46%
CURRENT VS TTM AVG
+79.59%
CURRENT VS 3Y AVG
+37.27%
CURRENT VS 5Y AVG
+25.53%
CURRENT VS 10Y AVG
+20.41%
CURRENT VS 15Y AVG
+4.37%
CURRENT VS 20Y AVG
+12.01%
SECTOR MEDIAN · HEALTHCARE
8.53%
median of 79 covered companies
CURRENT VS SECTOR MEDIAN
-1.99%
vs the sector median at left
Charles River Laboratories International, Inc.
Market Cap
$11.20B
Return on Invested Capital (ROIC)
8.36%
TTM Avg
4.65%
3Y Avg
6.09%
5Y Avg
6.66%
Market Cap
$11.29B
Return on Invested Capital (ROIC)
3.18%
TTM Avg
5.25%
3Y Avg
8.14%
5Y Avg
8.29%
Market Cap
$11.45B
Return on Invested Capital (ROIC)
13.62%
TTM Avg
12.65%
3Y Avg
8.97%
5Y Avg
7.27%
Market Cap
$10.37B
Return on Invested Capital (ROIC)
-24.28%
TTM Avg
-15.13%
3Y Avg
-6.38%
5Y Avg
-2.73%
Market Cap
$12.11B
Return on Invested Capital (ROIC)
9.94%
TTM Avg
9.96%
3Y Avg
10.13%
5Y Avg
11.66%
Market Cap
$10.21B
Return on Invested Capital (ROIC)
7.64%
TTM Avg
12.01%
3Y Avg
15.07%
5Y Avg
15.28%
Market Cap
$10.20B
Return on Invested Capital (ROIC)
11.29%
TTM Avg
10.92%
3Y Avg
8.93%
5Y Avg
9.01%
Market Cap
$12.55B
Return on Invested Capital (ROIC)
2.82%
TTM Avg
2.97%
3Y Avg
3.42%
5Y Avg
5.50%
Market Cap
$9.77B
Return on Invested Capital (ROIC)
6.58%
TTM Avg
6.66%
3Y Avg
7.75%
5Y Avg
8.24%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Charles River Laboratories International, Inc. (CRL) | $11.20B | 8.36% | 4.65% | 6.09% | 6.66% |
| Bio-Techne Corporation (TECH)vs › | $11.29B | 3.18% | 5.25% | 8.14% | 8.29% |
| Insulet Corp. (PODD)vs › | $11.45B | 13.62% | 12.65% | 8.97% | 7.27% |
| Walgreens Boots Alliance, Inc. (WBA)vs › | $10.37B | -24.28% | -15.13% | -6.38% | -2.73% |
| Align Technology, Inc. (ALGN)vs › | $12.11B | 9.94% | 9.96% | 10.13% | 11.66% |
| Molina Healthcare, Inc. (MOH)vs › | $10.21B | 7.64% | 12.01% | 15.07% | 15.28% |
| Universal Health Services, Inc. (UHS)vs › | $10.20B | 11.29% | 10.92% | 8.93% | 9.01% |
| Revvity, Inc. (RVTY)vs › | $12.55B | 2.82% | 2.97% | 3.42% | 5.50% |
| Henry Schein, Inc. (HSIC)vs › | $9.77B | 6.58% | 6.66% | 7.75% | 8.24% |
| Baxter International Inc. (BAX)vs › | $13.51B | -1.79% | -0.86% | -2.61% | 0.30% |
ROIC
8.4%
ROE
-6.3%
ROIC = NOPAT / Invested Capital
Return on invested capital measures the after-tax return a company earns on all capital (debt and equity) invested in the business.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2025-12-27 | 8.36% |
| 2024-12-28 | 0.95% |
| 2023-12-31 | 7.14% |
| 2022-12-31 | 7.91% |
| 2021-12-31 | 8.12% |
| 2020-12-31 | 7.48% |
| 2019-12-31 | 7.26% |
| 2018-12-31 | 8.02% |
| 2017-12-31 | 4.88% |
| 2016-12-31 | 7.20% |
| 2015-12-31 | 9.05% |
| 2014-12-31 | 8.02% |
| 2013-12-31 | 8.13% |
| 2012-12-31 | 9.43% |
| 2011-12-31 | 11.19% |
| 2010-12-31 | -19.85% |
| 2009-12-31 | 6.21% |
| 2008-12-31 | -23.74% |
| 2007-12-31 | 6.53% |
| 2006-12-31 | 5.82% |
| 2005-12-31 | 7.32% |
| 2004-12-31 | 4.01% |
| 2003-12-31 | 12.44% |
| 2002-12-31 | 12.87% |
| 2001-12-31 | 11.63% |
| 2000-12-31 | 13.05% |
| 1999-12-31 | 7.58% |
| 1998-12-31 | 12.42% |